192 related articles for article (PubMed ID: 33798677)
1. Targeting cellular stress in vitro improves osteoblast homeostasis, matrix collagen content and mineralization in two murine models of osteogenesis imperfecta.
Garibaldi N; Contento BM; Babini G; Morini J; Siciliani S; Biggiogera M; Raspanti M; Marini JC; Rossi A; Forlino A; Besio R
Matrix Biol; 2021 Apr; 98():1-20. PubMed ID: 33798677
[TBL] [Abstract][Full Text] [Related]
2. 4-Phenylbutyric acid enhances the mineralization of osteogenesis imperfecta iPSC-derived osteoblasts.
Takeyari S; Kubota T; Ohata Y; Fujiwara M; Kitaoka T; Taga Y; Mizuno K; Ozono K
J Biol Chem; 2021; 296():100027. PubMed ID: 33154166
[TBL] [Abstract][Full Text] [Related]
3. Cell differentiation and matrix organization are differentially affected during bone formation in osteogenesis imperfecta zebrafish models with different genetic defects impacting collagen type I structure.
Daponte V; Tonelli F; Masiero C; Syx D; Exbrayat-Héritier C; Biggiogera M; Willaert A; Rossi A; Coucke PJ; Ruggiero F; Forlino A
Matrix Biol; 2023 Aug; 121():105-126. PubMed ID: 37336269
[TBL] [Abstract][Full Text] [Related]
4. Osteoblast Malfunction Caused by Cell Stress Response to Procollagen Misfolding in α2(I)-G610C Mouse Model of Osteogenesis Imperfecta.
Mirigian LS; Makareeva E; Mertz EL; Omari S; Roberts-Pilgrim AM; Oestreich AK; Phillips CL; Leikin S
J Bone Miner Res; 2016 Aug; 31(8):1608-1616. PubMed ID: 26925839
[TBL] [Abstract][Full Text] [Related]
5. 4-PBA Treatment Improves Bone Phenotypes in the Aga2 Mouse Model of Osteogenesis Imperfecta.
Duran I; Zieba J; Csukasi F; Martin JH; Wachtell D; Barad M; Dawson B; Fafilek B; Jacobsen CM; Ambrose CG; Cohn DH; Krejci P; Lee BH; Krakow D
J Bone Miner Res; 2022 Apr; 37(4):675-686. PubMed ID: 34997935
[TBL] [Abstract][Full Text] [Related]
6. Makings of a brittle bone: Unexpected lessons from a low protein diet study of a mouse OI model.
Mertz EL; Makareeva E; Mirigian LS; Koon KY; Perosky JE; Kozloff KM; Leikin S
Matrix Biol; 2016; 52-54():29-42. PubMed ID: 27039252
[TBL] [Abstract][Full Text] [Related]
7. 4-PBA ameliorates cellular homeostasis in fibroblasts from osteogenesis imperfecta patients by enhancing autophagy and stimulating protein secretion.
Besio R; Iula G; Garibaldi N; Cipolla L; Sabbioneda S; Biggiogera M; Marini JC; Rossi A; Forlino A
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1642-1652. PubMed ID: 29432813
[TBL] [Abstract][Full Text] [Related]
8. Endoplasmic reticulum stress is induced in growth plate hypertrophic chondrocytes in G610C mouse model of osteogenesis imperfecta.
Scheiber AL; Guess AJ; Kaito T; Abzug JM; Enomoto-Iwamoto M; Leikin S; Iwamoto M; Otsuru S
Biochem Biophys Res Commun; 2019 Jan; 509(1):235-240. PubMed ID: 30579604
[TBL] [Abstract][Full Text] [Related]
9. Multiexon deletions in the type I collagen COL1A2 gene in osteogenesis imperfecta type IB. Molecules containing the shortened alpha2(I) chains show differential incorporation into the bone and skin extracellular matrix.
Mundlos S; Chan D; Weng YM; Sillence DO; Cole WG; Bateman JF
J Biol Chem; 1996 Aug; 271(35):21068-74. PubMed ID: 8702873
[TBL] [Abstract][Full Text] [Related]
10. Type V OI primary osteoblasts display increased mineralization despite decreased COL1A1 expression.
Reich A; Bae AS; Barnes AM; Cabral WA; Hinek A; Stimec J; Hill SC; Chitayat D; Marini JC
J Clin Endocrinol Metab; 2015 Feb; 100(2):E325-32. PubMed ID: 25387264
[TBL] [Abstract][Full Text] [Related]
11. Bone mineral properties in growing Col1a2(+/G610C) mice, an animal model of osteogenesis imperfecta.
Masci M; Wang M; Imbert L; Barnes AM; Spevak L; Lukashova L; Huang Y; Ma Y; Marini JC; Jacobsen CM; Warman ML; Boskey AL
Bone; 2016 Jun; 87():120-9. PubMed ID: 27083399
[TBL] [Abstract][Full Text] [Related]
12. Abnormal type I collagen post-translational modification and crosslinking in a cyclophilin B KO mouse model of recessive osteogenesis imperfecta.
Cabral WA; Perdivara I; Weis M; Terajima M; Blissett AR; Chang W; Perosky JE; Makareeva EN; Mertz EL; Leikin S; Tomer KB; Kozloff KM; Eyre DR; Yamauchi M; Marini JC
PLoS Genet; 2014 Jun; 10(6):e1004465. PubMed ID: 24968150
[TBL] [Abstract][Full Text] [Related]
13. First mouse model for combined osteogenesis imperfecta and Ehlers-Danlos syndrome.
Chen F; Guo R; Itoh S; Moreno L; Rosenthal E; Zappitelli T; Zirngibl RA; Flenniken A; Cole W; Grynpas M; Osborne LR; Vogel W; Adamson L; Rossant J; Aubin JE
J Bone Miner Res; 2014 Jun; 29(6):1412-23. PubMed ID: 24443344
[TBL] [Abstract][Full Text] [Related]
14. Cellular stress due to impairment of collagen prolyl hydroxylation complex is rescued by the chaperone 4-phenylbutyrate.
Besio R; Garibaldi N; Leoni L; Cipolla L; Sabbioneda S; Biggiogera M; Mottes M; Aglan M; Otaify GA; Temtamy SA; Rossi A; Forlino A
Dis Model Mech; 2019 Jun; 12(6):. PubMed ID: 31171565
[TBL] [Abstract][Full Text] [Related]
15. The effect of carbamazepine on bone structure and strength in control and osteogenesis imperfecta (Col1a2
Blank M; McGregor NE; Rowley L; Kung LHW; Crimeen-Irwin B; Poulton IJ; Walker EC; Gooi JH; Lamandé SR; Sims NA; Bateman JF
J Cell Mol Med; 2022 Jul; 26(14):4021-4031. PubMed ID: 35701367
[TBL] [Abstract][Full Text] [Related]
16. 4PBA reduces growth deficiency in osteogenesis imperfecta by enhancing transition of hypertrophic chondrocytes to osteoblasts.
Scheiber AL; Wilkinson KJ; Suzuki A; Enomoto-Iwamoto M; Kaito T; Cheah KS; Iwamoto M; Leikin S; Otsuru S
JCI Insight; 2022 Feb; 7(3):. PubMed ID: 34990412
[TBL] [Abstract][Full Text] [Related]
17. Molecular Consequences of the SERPINH1/HSP47 Mutation in the Dachshund Natural Model of Osteogenesis Imperfecta.
Lindert U; Weis MA; Rai J; Seeliger F; Hausser I; Leeb T; Eyre D; Rohrbach M; Giunta C
J Biol Chem; 2015 Jul; 290(29):17679-17689. PubMed ID: 26004778
[TBL] [Abstract][Full Text] [Related]
18. The chaperone activity of 4PBA ameliorates the skeletal phenotype of Chihuahua, a zebrafish model for dominant osteogenesis imperfecta.
Gioia R; Tonelli F; Ceppi I; Biggiogera M; Leikin S; Fisher S; Tenedini E; Yorgan TA; Schinke T; Tian K; Schwartz JM; Forte F; Wagener R; Villani S; Rossi A; Forlino A
Hum Mol Genet; 2017 Aug; 26(15):2897-2911. PubMed ID: 28475764
[TBL] [Abstract][Full Text] [Related]
19. Effect of rapamycin on bone mass and strength in the α2(I)-G610C mouse model of osteogenesis imperfecta.
Bateman JF; Sampurno L; Maurizi A; Lamandé SR; Sims NA; Cheng TL; Schindeler A; Little DG
J Cell Mol Med; 2019 Mar; 23(3):1735-1745. PubMed ID: 30597759
[TBL] [Abstract][Full Text] [Related]
20. Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans.
Marini JC; Forlino A; Cabral WA; Barnes AM; San Antonio JD; Milgrom S; Hyland JC; Körkkö J; Prockop DJ; De Paepe A; Coucke P; Symoens S; Glorieux FH; Roughley PJ; Lund AM; Kuurila-Svahn K; Hartikka H; Cohn DH; Krakow D; Mottes M; Schwarze U; Chen D; Yang K; Kuslich C; Troendle J; Dalgleish R; Byers PH
Hum Mutat; 2007 Mar; 28(3):209-21. PubMed ID: 17078022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
